TUSC2 and neoplasm: Meraz and his colleagues delivered TUSC2 (tumor suppressor that encodes a multikinase inhibitor and has been shown to be lost in non-small cell lung carcinoma) systemically by nanovesicles, which was shown to mediate tumor regression.